These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 23717698

  • 1. Microproteinuria during Opisthorchis viverrini infection: a biomarker for advanced renal and hepatobiliary pathologies from chronic opisthorchiasis.
    Saichua P, Sithithaworn P, Jariwala AR, Diemert DJ, Sithithaworn J, Sripa B, Laha T, Mairiang E, Pairojkul C, Periago MV, Khuntikeo N, Mulvenna J, Bethony JM.
    PLoS Negl Trop Dis; 2013; 7(5):e2228. PubMed ID: 23717698
    [Abstract] [Full Text] [Related]

  • 2. Levels of 8-OxodG Predict Hepatobiliary Pathology in Opisthorchis viverrini Endemic Settings in Thailand.
    Saichua P, Yakovleva A, Kamamia C, Jariwala AR, Sithithaworn J, Sripa B, Brindley PJ, Laha T, Mairiang E, Pairojkul C, Khuntikeo N, Mulvenna J, Sithithaworn P, Bethony JM.
    PLoS Negl Trop Dis; 2015; 9(7):e0003949. PubMed ID: 26230769
    [Abstract] [Full Text] [Related]

  • 3. Enhanced neutrophil functions during Opisthorchis viverrini infections and correlation with advanced periductal fibrosis.
    Salao K, Spofford EM, Price C, Mairiang E, Suttiprapa S, Wright HL, Sripa B, Edwards SW.
    Int J Parasitol; 2020 Feb; 50(2):145-152. PubMed ID: 32006550
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Detection of salivary antibodies to crude antigens of Opisthorchis viverrini in opisthorchiasis and cholangiocarcinoma patients.
    Chaiyarit P, Sithithaworn P, Thuwajit C, Yongvanit P.
    Clin Oral Investig; 2011 Aug; 15(4):477-83. PubMed ID: 20446100
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ultrasonographic features of hepatobiliary pathology in opisthorchiasis and opisthorchiasis-associated cholangiocarcinoma.
    Mairiang E.
    Parasitol Int; 2017 Aug; 66(4):378-382. PubMed ID: 27956092
    [Abstract] [Full Text] [Related]

  • 11. Association between Opisthorchis viverrini Infection and Glomerular Disease in Thailand.
    Tonsawan P, Intarak S, Sripa B, Puapairoj A, Sripa M, Sithithaworn P, Anutrakulchai S.
    Am J Nephrol; 2022 Aug; 53(2-3):199-206. PubMed ID: 35168235
    [Abstract] [Full Text] [Related]

  • 12. Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini.
    Sripa B, Thinkhamrop B, Mairiang E, Laha T, Kaewkes S, Sithithaworn P, Periago MV, Bhudhisawasdi V, Yonglitthipagon P, Mulvenna J, Brindley PJ, Loukas A, Bethony JM.
    PLoS Negl Trop Dis; 2012 Aug; 6(5):e1654. PubMed ID: 22629477
    [Abstract] [Full Text] [Related]

  • 13. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke Opisthorchis viverrini-Associated Advanced Periductal Fibrosis and Cholangiocarcinoma.
    Surapaitoon A, Suttiprapa S, Mairiang E, Khuntikeo N, Pairojkul C, Bethony J, Brindley PJ, Sripa B.
    Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954
    [Abstract] [Full Text] [Related]

  • 14. Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis.
    Rodpai R, Luvira V, Sadaow L, Sukeepaisarnjaroen W, Kitkhuandee A, Paonariang K, Sanpool O, Ittiprasert W, Mann VH, Intapan PM, Brindley PJ, Maleewong W.
    Int J Infect Dis; 2022 Mar; 116():80-84. PubMed ID: 34954313
    [Abstract] [Full Text] [Related]

  • 15. Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis.
    Wangboon C, Yongvanit P, Loilome W, Thanan R, Worasith C, Eamudomkarn C, Chamadol N, Mairiang E, Sithithaworn J, Saichua P, Sripa B, Khuntikeo N, Bethony JM, Sithithaworn P.
    Am J Trop Med Hyg; 2018 Jun; 98(6):1763-1769. PubMed ID: 29637887
    [Abstract] [Full Text] [Related]

  • 16. Recent Advances in the Diagnosis and Detection of Opisthorchis viverrini Sensu Lato in Human and Intermediate Hosts for Use in Control and Elimination Programs.
    Saijuntha W, Duenngai K, Tangkawattana S, Petney TN, Andrews RH, Sithithaworn P.
    Adv Parasitol; 2018 Jun; 101():177-214. PubMed ID: 29907254
    [Abstract] [Full Text] [Related]

  • 17. Opisthorchis viverrini Infection Induces Metabolic and Fecal Microbial Disturbances in Association with Liver and Kidney Pathologies in Hamsters.
    Haonon O, Liu Z, Dangtakot R, Intuyod K, Pinlaor P, Puapairoj A, Cha'on U, Sengthong C, Pongking T, Onsurathum S, Yingklang M, Phetcharaburanin J, Li JV, Pinlaor S.
    J Proteome Res; 2021 Aug 06; 20(8):3940-3951. PubMed ID: 34270897
    [Abstract] [Full Text] [Related]

  • 18. Hepatobiliary morbidities detected by ultrasonography in Opisthorchis viverrini-infected patients before and after praziquantel treatment: a five-year follow up study.
    Mairiang E, Laha T, Kaewkes S, Loukas A, Bethony J, Brindley PJ, Sripa B.
    Acta Trop; 2021 May 06; 217():105853. PubMed ID: 33548204
    [Abstract] [Full Text] [Related]

  • 19. Novel Potential Biomarkers for Opisthorchis viverrini Infection and Associated Cholangiocarcinoma.
    Aksorn N, Roytrakul S, Kittisenachai S, Leelawat K, Chanvorachote P, Topanurak S, Hamano S, Lek-Uthai U.
    In Vivo; 2018 May 06; 32(4):871-878. PubMed ID: 29936472
    [Abstract] [Full Text] [Related]

  • 20. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma.
    Yongvanit P, Pinlaor S, Loilome W.
    J Hepatobiliary Pancreat Sci; 2014 May 06; 21(5):309-15. PubMed ID: 24408859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.